Work

Implementation of quality indicators for ovarian cancer in gynecological cancer centers certified by the German Cancer Society (DKG)

Year: 2026
Type: article
Study design: Observational Study
Abstract: PURPOSE: Since 2008, the German Cancer Society (DKG) has certified gynecological cancer centers to ensure high-quality care with guideline-based quality indicators (QI) as a core component. This article summarizes the German development and update of ovarian cancer (OC) QI based on the current S3-guideline (2026) and presents their performance. METHODS: This was a retrospective, descriptive, observational analysis of aggregated annual-report data for treatment years 2019-2024; no inferential statistics were performed. QI were derived from strong S3-guideline recommendations through a structured multi-step process. Experts identified potential QI according to standardized criteria (including feasibility and impact on care). QI required ≥ 75% agreement. Since 2017, each tumor entity has been limited to five key QI in the certification dataset. RESULTS: Eight guideline-derived QI are currently defined for OC, five QI are included in the certification program. In 2024, 184 certified centers treated 4.951 primary OC cases. At center level, the predefined target values were met for surgical staging (93.5% of centers; target ≥ 40%), offering genetic testing (97.8%; target ≥ 70%), complete macroscopic resection (99.5%; target ≥ 30%), and surgery by a gynecologic oncologist (98.9%; target ≥ 80%). All centers (100%) met plausibility limits for first-line chemotherapy (75.1% of advanced-stage patients). At patient level, pooled adherence rates improved over time; the median rate of offering genetic testing rose from 61% (2019) to 84% (2024). Two QI were retired in 2021, and one QI is pending until further guideline updates. CONCLUSION: Guideline-based QI translate essential recommendations into measurable metrics, allowing objective assessment of quality. High and increasing adherence rates were observed in certified centers. These findings support the use of guideline-based QI for benchmarking and continuous quality improvement, although the observational design precludes causal attribution to certification.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
Estimated APC paid: $4,390
OpenAlex ID: W7212509845
FWCI:
Cites: 29
Cited by:
Related to: 9